一个基于血液的测试用于结肠直肠癌查
1HCA Florida St Lucie Hospital, Port St Lucie, Florida.
HCA healthcare journal of medicine
|January 14, 2026
概括
一项针对结直肠癌 (CRC) 查的新血液测试显示,增加检测率是有前途的. 这种非侵入性DNA测试,Shield,可以帮助更多的人接受查,并可能减少美国的CRC死亡率.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 公共卫生 公共卫生
背景情况:
- 结肠直肠癌 (CRC) 是美国癌症死亡的主要原因,查率低于国家目标.
- 目前的查方法有局限性,需要使用非侵入性选择来提高遵守率.
- 国家结肠直肠癌圆桌会议的目标是80%的结肠直肠癌查,这是美国尚未实现的目标.
研究的目的:
- 审查FDA批准的盾牌基于血液的DNA测试用于结直肠癌 (CRC) 查.
- 分析ECLIPSE试验结果,这些结果支持FDA批准Shield.
- 评估在常规临床实践中实施"盾牌"的潜在好处,风险和成本效益.
主要方法:
- 在PubMed搜索"基于血液的结直肠癌查"文章.
- 专注于与盾牌测试及其FDA批准相关的研究.
- 关于ECLIPSE队列试验数据的概述.
主要成果:
- 盾牌测试是美国FDA批准的CRC的第一个基于血液的DNA查测试.
- 美国FDA的批准是基于大型ECLIPSE队列试验.
- 该研究提供了关于Shield在现实环境中的性能数据.
结论:
- 基于血液的CRC查测试,如"盾牌",有可能提高查率.
- 更广泛地采用有效的查可能会导致CRC相关死亡率的降低.
- 对益处,风险和成本的进一步分析对于临床实施至关重要.
相关概念视频
Serum Laboratory Studies, Stool Test, Breath Test
761
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
761
Assessment of the Rectum and Anus
1.1K
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
1.1K


